10x Genomics expands autoimmune biomarker research with two new collaborations
TXG•
TXG•10x Genomics announced two collaborations to study blood-based biomarkers for autoimmune disease activity and treatment response, using Flex Apex to analyze samples over time at single-cell resolution. One study will involve 750 patients with rheumatoid arthritis, lupus or psoriatic arthritis; another will study moderate-to-severe alopecia areata.
10x Genomics announced collaborations with Charité and DRFZ, and with Seoul National University, to identify blood-based biomarkers for autoimmune disease activity and treatment response. Both collaborations plan to use Flex Apex to analyze blood samples over time at single-cell resolution and link immune profiles with clinical outcomes.
Charité and DRFZ plan a multiyear study involving 750 patients with rheumatoid arthritis, lupus or psoriatic arthritis. Researchers at Seoul National University will study moderate-to-severe alopecia areata and seek biomarkers that predict response to JAK inhibitor therapy.